Iobenzamic acid

Iobenzamic acid
Clinical data
ATC code	V08AC05 (WHO) ;
Identifiers
	IUPAC name 3-[1-(3-amino-2,4,6-triiodophenyl)-N-phenylformamido]propanoic acid;
CAS Number	3115-05-7;
PubChem CID	18377;
DrugBank	DB13428;
ChemSpider	17355;
UNII	F72UWG2SWK;
KEGG	D01313;
CompTox Dashboard (EPA)	DTXSID9057711 ;
ECHA InfoCard	100.019.531
Chemical and physical data
Formula	C16H13I3N2O3
Molar mass	662.004 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Ic1c(c(I)c(N)c(I)c1)C(=O)N(c2ccccc2)CCC(=O)O;
	InChI InChI=1S/C16H13I3N2O3/c17-10-8-11(18)15(20)14(19)13(10)16(24)21(7-6-12(22)23)9-4-2-1-3-5-9/h1-5,8H,6-7,20H2,(H,22,23); Key:FJYJNLIEGUTPIJ-UHFFFAOYSA-N;

Iobenzamic acid is a pharmaceutical drug used as an X-ray contrast agent.^[1]

It is a water-soluble, hepatotropic contrast medium, meaning it is taken up by the liver and gallbladder. This makes it useful for imaging these organs.^[2]

References

^ DrugBank DB13428 . Accessed 2021-03-18.
^ "Iobenzamic acid - PubChem Compound Summary". PubChem. Retrieved July 18, 2023.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

[1] DrugBank DB13428 . Accessed 2021-03-18.

[2] "Iobenzamic acid - PubChem Compound Summary". PubChem. Retrieved July 18, 2023.

[1]

[2]

See also

References